The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00751543 |
Recruitment Status
: Unknown
Verified June 2010 by National Taiwan University Hospital.
Recruitment status was: Recruiting
First Posted
: September 12, 2008
Last Update Posted
: June 29, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Adenocarcinoma Squamous Cell Carcinoma Relevant Condition Terms to the Conditions Field | Radiation: CT, radiation therapy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 20 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy |
Study Start Date : | January 2008 |
Estimated Primary Completion Date : | December 2010 |

-
Radiation: CT, radiation therapy
- This study will provide information of quantitative measurement of lung cancer, in term of tumor permeability (mL/100 mL/min) and blood volume (mL/100 mL), in addition to tumor size. [ Time Frame: Dec, 2008 ]
- The information may be beneficial to understand the longitudinal change of internal tumor vascular composition following radiation therapy and between tumors of different histopathology (i.e. adenocarcinoma vs. squamous cell carcinoma). [ Time Frame: Dec, 2008 ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Ages 18 and up
- Males and females
Exclusion Criteria:
- Pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00751543
Contact: Chang Yeun-Chung, Ph.D | 886-2-23123456 ext 65566 | ycc5566@ntu.edu.tw |
Taiwan | |
Yeun-Chung Chang | Recruiting |
Taipei, Taiwan, 100 |
Principal Investigator: | Yeun-Chung Chang, Ph.D | National Taiwan University Hospital |
Responsible Party: | Yeun-Chung Chang / Department of Medical Imaging, National Taiwan University Hospital |
ClinicalTrials.gov Identifier: | NCT00751543 History of Changes |
Other Study ID Numbers: |
200705059R |
First Posted: | September 12, 2008 Key Record Dates |
Last Update Posted: | June 29, 2010 |
Last Verified: | June 2010 |
Keywords provided by National Taiwan University Hospital:
To evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion MDCT Comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion MDCT |
Additional relevant MeSH terms:
Carcinoma Carcinoma, Squamous Cell Adenocarcinoma Disease Lung Neoplasms Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms |
Neoplasms, Squamous Cell Pathologic Processes Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site Lung Diseases Respiratory Tract Diseases |